Sanofi and GSK initiate global Phase 3 clinical efficacy study of COVID-19 vaccine candidate
tarted enrollment in their Phase 3 clinical study to assess the safety,
Source:
Biospace Inc.
tarted enrollment in their Phase 3 clinical study to assess the safety,
Biospace Inc.